Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Kausik K. Ray
Based on 10 articles published since 2009
(Why 10 articles?)
||||
Expertise Level
The expertise of Kausik K. Ray ranks in the
  • Top 0.24%
  • ... of 27,574 published authors worldwide on Hypercholesterolemia
  • ... from 2009 through 2019
  • ... based on contributions to 10 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Ray, K K   ·   Ray, Kausik K
Work Locations
Details
Most likely:    Imperial College London      
2019
  • From the Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College London, London (K.K.R.) · the Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY (H.E.B.) · the University of Milan and Multimedica IRCCS, Milan (A.L.C.) · Esperion Therapeutics, Ann Arbor, MI (N.D.L., L.T.B., L.R.S., P.L.R.) · and Baylor College of Medicine, Houston (C.M.B.). · Pubmed 30865796
2017
  • Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. · Department of Endocrinology, l'institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, Nantes, France. · Department of Internal Medicine I, University Hospital RWTH Aachen, Aachen, Germany. · University of Edinburgh, Edinburgh, UK. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Hospital Virgen de la Victoria, CIBERobn, Málaga University, Málaga, Spain. · Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK. · Sanofi, Paris, France. · Sanofi, Gentilly, France. · Sanofi, Chilly-Mazarin, France. · IviData Stats, Levallois-Perret, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · University of California San Diego School of Medicine, and Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, California. · Pubmed 28905478
  • Institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, 44093 Nantes cedex 1, France. Electronic address: · Li KaShing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. · Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany. · IVIDATA, 92300 Levallois-Perret, France. · University of Edinburgh, Edinburgh, Scotland, UK. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · University of California San Diego School of Medicine, Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, CA, USA. · CIBERobn, Hospital Virgen de la Victoria, Málaga University, Spain. · Sanofi, 91380 Chilly-Mazarin, France. · Sanofi, Bridgewater, NJ, USA. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Department of Primary Care and Public Health, School of Public Health, Imperial College, London, UK. · Sanofi, 75008 Paris, France. · Pubmed 28347654
  • From the Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College London, London (K.K.R.), and Knowle House Surgery, Plymouth (T.H.) - both in the United Kingdom · the Department of Cardiology, Charité-Universitätsmedizin Berlin, Berlin Institute of Health and German Center for Cardiovascular Research, Berlin (U.L.), and University Heart Center Hamburg, Department of General and Interventional Cardiology, Hamburg (M.K.) - all in Germany · the Division of Endocrinology and Metabolism, Li Ka Shing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) · the Medicines Company, Parsippany, NJ (D.K., P.W.) · Institut de Recherches Cliniques de Montréal, University of Montreal, Montreal (R.D.) · the Department of Cardiology and Interventional Cardiology, VieCuri Medical Center for Northern Limburg, Venlo (R.P.T.T.), University Medical Center, Utrecht (F.L.J.V.), and the Department of Vascular Medicine, Academic Medical Center-University of Amsterdam, Amsterdam (J.J.P.K.) - all in the Netherlands · the Metabolic and Atherosclerosis Research Center, Medpace, Cincinnati (T.T.) · and the Department of Cardiology, Mayo Clinic, Rochester, MN (R.S.W.). · Pubmed 28306389
  • Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, United Kingdom (A.J.V.-V., K.K.R.). · Robertson Centre for Biostatistics, University of Glasgow, United Kingdom (M.R., I.F.). · Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano and IRCCS Multimedica, Italy (A.L.C.). · Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia (G.F.W.). · Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands (J.J.K.). · College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom (C.J.P.). · Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, United Kingdom (A.J.V.-V., K.K.R.). · Pubmed 28877913
  • Division of Cardiovascular Medicine, Wayne State University School of Medicine, Detroit, Michigan. · Institute for Advanced Studies, University of Bristol, Bristol, United Kingdom. · Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. · Irving Institute for Clinical and Translational Research, Columbia University College of Physicians and Surgeons, New York, New York. · National Institute for Health and Medical Research (INSERM), Pitie-Salpetriere University Hospital, Paris, France. · South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia. · Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, United Kingdom. · Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom. · Department of Cardiology, University of Leipzig, Leipzig, Germany. · Division of Cardiovascular Medicine, University of Michigan Medical School, Ann Arbor. · MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. · National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, United Kingdom. · Wellcome Trust Sanger Institute, Hinxton, United Kingdom. · MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom. · Department of Pharmacological and Biomolecular Sciences, University of Milan and Multimedica IRCCS, Milano, Italy. · Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 28846118
  • a Bekes County Central Hospital Pandy Kalman Section , Department of Cardiology , Gyula , Hungary. · b Medical and Health Science Centre , University of Debrecen, 1st Department of Medicine , Debrecen , Hungary. · c Department of Primary Care and Public Health , School of Public Health, Imperial College London , London , UK. · Pubmed 27599680
2015
  • Department of Vascular Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. · Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK. · Department of Vascular Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. · Pubmed 26482752
2019
  • From the Centre for Naturally Randomized Trials (B.A.F., T.B.F.), Medical Research Council, British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care (B.A.F., S.B., C.O.-W., A.M.W., A.S.B., E.D.A., J.D.), Medical Research Council Biostatistics Unit (S.B.), and NIHR Blood and Transplant Research Unit in Donor Health and Genomics (A.S.B., E.D.A., J.D.), University of Cambridge, Cambridge, and Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, London (K.K.R.) - all in the United Kingdom · the Department of Pharmacologic and Biomolecular Sciences, University of Milan and Multimedica IRCCS, Milan (A.L.C.) · Michigan State University, East Lansing (D.R.N.) · the Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam (J.J.P.K.) · and Monash University, Clayton, VIC, Australia (S.J.N.). · Pubmed 30865797
Probable:    University of London      
2014
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Kausik K. Ray in 2009-2019 about Hypercholesterolemia:

  • Mendelian Randomization Study of 2019
  • Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol. 2019
  • Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM-INSULIN randomized trial. 2017
  • Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM-INSULIN trial. 2017
  • Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol. 2017
  • Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up. 2017
  • Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk. 2017
  • The need for a new classification of cholesterol lowering therapies. 2017
  • New Approaches in Detection and Treatment of Familial Hypercholesterolemia. 2015
  • The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011. 2014
Show List of Full Article Records
Google Searches

Learn more about Kausik K. Ray using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Imperial College London
University of London
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Imperial College London
2019
  • From the Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College London, London (K.K.R.) · the Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY (H.E.B.) · the University of Milan and Multimedica IRCCS, Milan (A.L.C.) · Esperion Therapeutics, Ann Arbor, MI (N.D.L., L.T.B., L.R.S., P.L.R.) · and Baylor College of Medicine, Houston (C.M.B.). · Pubmed 30865796
2017
  • Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. · Department of Endocrinology, l'institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, Nantes, France. · Department of Internal Medicine I, University Hospital RWTH Aachen, Aachen, Germany. · University of Edinburgh, Edinburgh, UK. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Hospital Virgen de la Victoria, CIBERobn, Málaga University, Málaga, Spain. · Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK. · Sanofi, Paris, France. · Sanofi, Gentilly, France. · Sanofi, Chilly-Mazarin, France. · IviData Stats, Levallois-Perret, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · University of California San Diego School of Medicine, and Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, California. · Pubmed 28905478
  • Institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, 44093 Nantes cedex 1, France. Electronic address: · Li KaShing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. · Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany. · IVIDATA, 92300 Levallois-Perret, France. · University of Edinburgh, Edinburgh, Scotland, UK. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · University of California San Diego School of Medicine, Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, CA, USA. · CIBERobn, Hospital Virgen de la Victoria, Málaga University, Spain. · Sanofi, 91380 Chilly-Mazarin, France. · Sanofi, Bridgewater, NJ, USA. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Department of Primary Care and Public Health, School of Public Health, Imperial College, London, UK. · Sanofi, 75008 Paris, France. · Pubmed 28347654
  • From the Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College London, London (K.K.R.), and Knowle House Surgery, Plymouth (T.H.) - both in the United Kingdom · the Department of Cardiology, Charité-Universitätsmedizin Berlin, Berlin Institute of Health and German Center for Cardiovascular Research, Berlin (U.L.), and University Heart Center Hamburg, Department of General and Interventional Cardiology, Hamburg (M.K.) - all in Germany · the Division of Endocrinology and Metabolism, Li Ka Shing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) · the Medicines Company, Parsippany, NJ (D.K., P.W.) · Institut de Recherches Cliniques de Montréal, University of Montreal, Montreal (R.D.) · the Department of Cardiology and Interventional Cardiology, VieCuri Medical Center for Northern Limburg, Venlo (R.P.T.T.), University Medical Center, Utrecht (F.L.J.V.), and the Department of Vascular Medicine, Academic Medical Center-University of Amsterdam, Amsterdam (J.J.P.K.) - all in the Netherlands · the Metabolic and Atherosclerosis Research Center, Medpace, Cincinnati (T.T.) · and the Department of Cardiology, Mayo Clinic, Rochester, MN (R.S.W.). · Pubmed 28306389
  • Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, United Kingdom (A.J.V.-V., K.K.R.). · Robertson Centre for Biostatistics, University of Glasgow, United Kingdom (M.R., I.F.). · Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano and IRCCS Multimedica, Italy (A.L.C.). · Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia (G.F.W.). · Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands (J.J.K.). · College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom (C.J.P.). · Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, United Kingdom (A.J.V.-V., K.K.R.). · Pubmed 28877913
  • Division of Cardiovascular Medicine, Wayne State University School of Medicine, Detroit, Michigan. · Institute for Advanced Studies, University of Bristol, Bristol, United Kingdom. · Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. · Irving Institute for Clinical and Translational Research, Columbia University College of Physicians and Surgeons, New York, New York. · National Institute for Health and Medical Research (INSERM), Pitie-Salpetriere University Hospital, Paris, France. · South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia. · Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, United Kingdom. · Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom. · Department of Cardiology, University of Leipzig, Leipzig, Germany. · Division of Cardiovascular Medicine, University of Michigan Medical School, Ann Arbor. · MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. · National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, United Kingdom. · Wellcome Trust Sanger Institute, Hinxton, United Kingdom. · MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom. · Department of Pharmacological and Biomolecular Sciences, University of Milan and Multimedica IRCCS, Milano, Italy. · Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 28846118
  • a Bekes County Central Hospital Pandy Kalman Section , Department of Cardiology , Gyula , Hungary. · b Medical and Health Science Centre , University of Debrecen, 1st Department of Medicine , Debrecen , Hungary. · c Department of Primary Care and Public Health , School of Public Health, Imperial College London , London , UK. · Pubmed 27599680
2015
  • Department of Vascular Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. · Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK. · Department of Vascular Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. · Pubmed 26482752
2019
  • From the Centre for Naturally Randomized Trials (B.A.F., T.B.F.), Medical Research Council, British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care (B.A.F., S.B., C.O.-W., A.M.W., A.S.B., E.D.A., J.D.), Medical Research Council Biostatistics Unit (S.B.), and NIHR Blood and Transplant Research Unit in Donor Health and Genomics (A.S.B., E.D.A., J.D.), University of Cambridge, Cambridge, and Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, London (K.K.R.) - all in the United Kingdom · the Department of Pharmacologic and Biomolecular Sciences, University of Milan and Multimedica IRCCS, Milan (A.L.C.) · Michigan State University, East Lansing (D.R.N.) · the Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam (J.J.P.K.) · and Monash University, Clayton, VIC, Australia (S.J.N.). · Pubmed 30865797
University of London
2014
3 Other Locations Show
Yearly article counts 20601100000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.